Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Conversation
The Conversation
Julian Koplin, Lecturer in Bioethics, Monash University & Honorary fellow, Melbourne Law School, Monash University

The rich are pouring millions into life extension research – but does it have any ethical value?

Sam Altman, the chief executive of OpenAI, recently invested US$180 million into Retro Biosciences – a company seeking to extend human lifespans by ten healthy years.

One way it plans to achieve this is by “rejuvenating” blood. This idea is based on studies that found old mice showed signs of reversed ageing when given the blood of young mice.

Altman isn’t the only Silicon Valley entrepreneur supporting life extension efforts. PayPal cofounder Peter Thiel, Amazon founder Jeff Bezos and Google cofounder Larry Page have poured millions into projects that could profoundly affect how we live our lives.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.